TES and hematologic disorder: Tatarelli et al. [90] observed lack of TESTIN expression in 22% of cancer cell lines and 44% of the cell lines derived from hematological malignancies, suggesting that TESTIN may represent a candidate tumor suppressor gene at 7q31.